Your browser doesn't support javascript.
loading
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice.
Forsberg, Elin M V; Lindberg, Mattias F; Jespersen, Henrik; Alsén, Samuel; Bagge, Roger Olofsson; Donia, Marco; Svane, Inge Marie; Nilsson, Ola; Ny, Lars; Nilsson, Lisa M; Nilsson, Jonas A.
Afiliación
  • Forsberg EMV; The Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
  • Lindberg MF; Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Jespersen H; The Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
  • Alsén S; Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Bagge RO; The Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
  • Donia M; Department of Oncology, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Svane IM; The Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
  • Nilsson O; Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Ny L; The Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
  • Nilsson LM; Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Nilsson JA; The Center of Cancer Immunotherapy, Copenhagen University Hospital, Herlev, Denmark.
Cancer Res ; 79(5): 899-904, 2019 03 01.
Article en En | MEDLINE | ID: mdl-30622115

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Linfocitos T / Inmunoterapia Adoptiva / Receptor ErbB-2 / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Linfocitos T / Inmunoterapia Adoptiva / Receptor ErbB-2 / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos